| 7.56 0.06 (0.8%) | 11-11 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 10.3 | 1-year : | 11.39 |
| Resists | First : | 8.82 | Second : | 9.76 |
| Pivot price | 8.25 |
|||
| Supports | First : | 7.3 | Second : | 6.08 |
| MAs | MA(5) : | 7.65 |
MA(20) : | 8.39 |
| MA(100) : | 8.01 |
MA(250) : | 8.62 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 8.9 |
D(3) : | 7.6 |
| RSI | RSI(14): 41.2 |
|||
| 52-week | High : | 15.21 | Low : | 6.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ TDOC ] has closed above bottom band by 19.0%. Bollinger Bands are 54.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 7.63 - 7.68 | 7.68 - 7.72 |
| Low: | 7.34 - 7.4 | 7.4 - 7.45 |
| Close: | 7.48 - 7.56 | 7.56 - 7.63 |
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Tue, 11 Nov 2025
Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit - TradingView
Mon, 10 Nov 2025
How is Teladoc Health Placed in the Growing Telemedicine Market? - Yahoo Finance
Sat, 08 Nov 2025
Assessing Teladoc Health (TDOC) Valuation: Is There Hidden Potential After Recent Share Price Weakness? - Yahoo Finance
Thu, 06 Nov 2025
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 - GlobeNewswire
Fri, 31 Oct 2025
Teladoc Health (TDOC): Ongoing Losses Persist, Testing Value Narrative at 0.6x Price-to-Sales - Sahm
Thu, 30 Oct 2025
Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 177 (M) |
| Shares Float | 175 (M) |
| Held by Insiders | 0.9 (%) |
| Held by Institutions | 74 (%) |
| Shares Short | 24,930 (K) |
| Shares Short P.Month | 23,820 (K) |
| EPS | -1.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.05 |
| Profit Margin | -8.2 % |
| Operating Margin | -7.3 % |
| Return on Assets (ttm) | -3.6 % |
| Return on Equity (ttm) | -14.2 % |
| Qtrly Rev. Growth | -1.7 % |
| Gross Profit (p.s.) | 10.13 |
| Sales Per Share | 14.37 |
| EBITDA (p.s.) | 0.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 303 (M) |
| Levered Free Cash Flow | 210 (M) |
| PE Ratio | -6.58 |
| PEG Ratio | 0 |
| Price to Book value | 0.93 |
| Price to Sales | 0.52 |
| Price to Cash Flow | 4.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |